NCT05919511

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Study Contact:

Incyte Corporation Call Center (US) - Role: CONTACT - Phone: 1.855.463.3463 - Email: medinfo@incyte.com
Incyte Corporation Call Center (ex-US) - Role: CONTACT - Phone: +800 00027423 - Email: eumedinfo@incyte.com

Study Phase:

Recruitment Status:

RECRUITING

NCT ID:

NCT05919511

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Summary

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Eligibility

Inclusion Criteria:

* Age ≥ 18 years inclusive at the time of signing the ICF
* Allogeneic SCT 90 to 180 days prior to enrollment
* Able to comprehend and willing to provide informed consent
* Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

Exclusion Criteria:

* There are no exclusion criteria for this study

Disease(s) and\or Condition(s)

cGVHD

Primary Purpose

Intervention/Treatment

- Type: OTHER
- Name: Non-Interventional
- Description: This is an observational study
- Arm Group Labels: At risk for GVHD

Sponsor

Incyte Corporation